Security key
629444209
NRX Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (NRXP)
CUSIP: 629444209
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 2,260,524
- Total 13F value
- $4,602,262
- Share change
- +1,211,882
- Put/Call ratio
- 0%
- SEC-reported price per share
- $2.05
- Number of holders
- 22
- Value change
- +$2,464,504
- Number of buys
- 10
- Number of sells
- 12
- Shares outstanding
- 35,443,612
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
22
Top holders
10
NRXP full security history
Ownership snapshot
Full 13F holder table
NRX Pharmaceuticals, Inc. SEC filings
NRX Pharmaceuticals, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of NRXP - NRX Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
AdvisorShares Investments...
Disclosed value leader
AdvisorShares Investments...
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F
Lead comparable stake: 0.88%
Showing 1-6 of 15 holder rows.
Quick read
AdvisorShares Investments LLC leads the comparable SEC ownership view at 0.88%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens AdvisorShares Investments LLC's linked filing trail.
Comparable ownership
Top 5
AdvisorShares Investments LLC
0.88%
VANGUARD GROUP INC
0.68%
Anson Funds Management LP
0.52%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
0.23%
GEODE CAPITAL MANAGEMENT, LLC
0.21%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| AdvisorShares Investments LLC |
13F
Company
|
0.88%
|
$682,691
310,314 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
0.68%
|
$528,695
240,316 shares
|
— | 31 Dec 2024 |
| Anson Funds Management LP |
13F
Company
|
0.52%
|
$408,452
185,660 shares
|
— | 31 Dec 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
0.23%
|
$180,734
82,152 shares
|
— | 31 Dec 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.21%
|
$163,389
74,251 shares
|
— | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
0.08%
|
$63,965
29,075 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
22
Shares
2,260,524
Rows available
22
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
22
Q1 2025 holders
22
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|